Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
Saved in:
| Title: | Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. |
|---|---|
| Authors: | Almansour SA; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates., Alqudah MAY; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Abuhelwa Z; Department of Hematology and Medical Oncology, University of South Florida/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Al-Shamsi HO; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.; College of Medicine, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.; Emirates Oncology Society, Dubai, United Arab Emirates.; Gulf Medical University, Ajman, United Arab Emirates.; Gulf Cancer Society, Alsafa, Kuwait., Alhuraiji A; Department of Haematology, Kuwait Cancer Control Center, Kuwait., Semreen MH; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, University of Sharjah, Sharjah, United Arab Emirates., Bustanji Y; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; School of Pharmacy, The University of Jordan, Amman, Jordan., Alzoubi KH; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Modi ND; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Mckinnon RA; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Abuhelwa AY; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Sep 02; Vol. 16, pp. 17588359241275387. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359241275387 |
